Show simple item record
Author | dc.contributor.author | Riester, Scott M. | |
Author | dc.contributor.author | Torres-Mora, Jorge | |
Author | dc.contributor.author | Dudakovic, Amel | |
Author | dc.contributor.author | Camilleri, Emily T. | |
Author | dc.contributor.author | Wang, Wei | |
Author | dc.contributor.author | Xu, Fuhua | |
Author | dc.contributor.author | Thaler, Roman R. | |
Author | dc.contributor.author | Evans, Jared M. | |
Author | dc.contributor.author | Zwartbol, René | |
Author | dc.contributor.author | Briaire-de Bruijn, Inge H. | |
Author | dc.contributor.author | Maran, Avudaiappan | |
Author | dc.contributor.author | Folpe, Andrew L. | |
Author | dc.contributor.author | Inwards, Carrie Y. | |
Author | dc.contributor.author | Rose, Peter S. | |
Author | dc.contributor.author | Shives, Thomas C. | |
Admission date | dc.date.accessioned | 2019-03-18T11:54:22Z | |
Available date | dc.date.available | 2019-03-18T11:54:22Z | |
Publication date | dc.date.issued | 2017 | |
Cita de ítem | dc.identifier.citation | Journal of Orthopaedic Research, Volumen 35, Issue 5, 2018, Pages 1137-1146 | |
Identifier | dc.identifier.issn | 1554527X | |
Identifier | dc.identifier.issn | 07360266 | |
Identifier | dc.identifier.other | 10.1002/jor.23344 | |
Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/166818 | |
Abstract | dc.description.abstract | © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. Osteoblastoma is a benign bone tumor that can often be difficult to distinguish from malignant osteosarcoma. Because misdiagnosis can result in unfavorable clinical outcomes, we have investigated microRNAs as potential diagnostic biomarkers for distinguishing between these two tumor types. Next generation RNA sequencing was used as an expression screen to evaluate >2,000 microRNAs present in tissue derived from rare formalin fixed paraffin embedded (FFPE) archival tumor specimens. MicroRNAs displaying the greatest ability to discriminate between these two tumors were validated on an independent tumor set, using qPCR assays. Initial screening by RNA-seq identified four microRNA biomarker candidates. Expression of three miRNAs (miR-451a, miR-144-3p, miR-486-5p) was higher in osteoblastoma, while the miR-210 was elevated in osteosarcoma. Validation of these microRNAs on an independent data set of 22 tumor specimens | |
Lenguage | dc.language.iso | en | |
Publisher | dc.publisher | John Wiley and Sons Inc. | |
Type of license | dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
Link to License | dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
Source | dc.source | Journal of Orthopaedic Research | |
Keywords | dc.subject | biomarker | |
Keywords | dc.subject | FFPE | |
Keywords | dc.subject | microRNA | |
Keywords | dc.subject | osteoblastoma | |
Keywords | dc.subject | osteosarcoma | |
Título | dc.title | Hypoxia-related microRNA-210 is a diagnostic marker for discriminating osteoblastoma and osteosarcoma | |
Document type | dc.type | Artículo de revista | |
Cataloguer | uchile.catalogador | SCOPUS | |
Indexation | uchile.index | Artículo de publicación SCOPUS | |
uchile.cosecha | uchile.cosecha | SI | |
Files in this item
- Name:
- item_84977072773.pdf
- Size:
- 2.568Kb
- Format:
- PDF
This item appears in the following Collection(s)
Show simple item record
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile